Osteopontin as a potential molecular target for ovarian clear cell carcinoma therapy. 1 34 PLD (1,445) Stage V (5.5), renal biopsy: thrombotic microangiopathy, HD <1y, stable to improved Cr PD: on T 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results